Circulating antipericyte autoantibodies: A novel modifier of risk of progression of diabetic retinopathy?

Retina

Volumn 27, Issue 2, 2007, Pages 211-215

  Nayak, Ramesh C ^a,c,d   Lynch, Kristian ^b   Gustavsson, Carin ^b   Kwok, Michael G K ^c   Farthing Nayak, Pamela J ^a,c   Agardh, Carl David ^a,b   Agardh, Elisabet ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Biomedical Research Laboratories G107   (United States)

Author keywords

Circulating antipericyte autoantibodies; Progression; Retinopathy; Type 2 diabetes

Indexed keywords

AUTOANTIBODY; BIOCHEMICAL MARKER;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERICYTE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TISSUE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PERICYTES; PROSPECTIVE STUDIES; RETINAL NEOVASCULARIZATION; RISK FACTORS;

EID: 33846958395     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000230397.24818.62     Document Type: Article

References (15)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865.
3. The Diabetes Control and Complications Trial Research Group. The relationship of glycaemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-983.
4. Chase HP, Garg SK, Jackson WE, et al. Blood pressure and retinopathy in type I diabetes. Ophthalmology 1990;97:155-159.
5. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1999;317:703-713.
6. Attawia MA, Nayak RC. Circulating antipericyte autoantibodies in diabetic retinopathy. Retina 1999;19:390-400.
7. Nayak RC, Agardh C-D, Kwok MGK, et al. Circulating anti-pericyte autoantibodies are present in type 2 diabetic patients and are associated with non-proliferative retinopathy. Diabetologia 2003;46:511-513.
8. Reynolds T. Declaration of Helsinki revised. J Natl Cancer Inst 2000;92:1801-1803.
9. Claudi T, Cooper JG. Comparison of urinary albumin excretion rate in overnight urine and albumin creatinine ratio in spot urine in diabetic patients in general practice. Scand J Prim Health Care 2001;19:247-248.
10. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991 98:S823-833.
11. Nayak RC, Herman IM. Bovine retinal microvascular pericytes: isolation, propagation and identification. In: Murray C, ed. Methods in Molecular Medicine: Angiogenesis Protocols. Totowa, NJ: Humana Press, Inc.; 2001:247-263.
12. Nayak RC, Agardh CD, Kwok MGK, et al. Albuminuria and hypertension are independently associated with circulating anti-pericyte autoantibodies in type 2 diabetic patients. Metabolism: Clinical and Experimental 2005;54:188-193.
13. Hiernaux J. Antiidiotypic networks. Fed Proc 1981;40:1484-1488.
14. Schluter SF, Adelman MK, Taneja V, et al. Natural autoantibodies to TCR public idiotopes: potential roles in immunomodulation. Cell Mol Biol 2003;49:193-207.
15. Robey IF, Schluter SF, Akporiaye E, et al. Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells. Immunology 2002;105:419-429.